Cart

0

Business

“Bristol-Myers to buy heart drugs developer MyoKardia for about $13 billion”

“Bristol-Myers Squibb said on Monday it would buy MyoKardia for about $13 billion to bolster its portfolio of heart disease treatments, as it seeks to reduce some of its dependence on cancer drugs. The deal follows Bristol-Myers’ $74 billion acquisition of Celgene last… Continue Reading…

Stocks

“3 Big Dividend Stocks Yielding Over 13%; RBC Says ‘Buy’”

“Energy Transfer LP (ET)… Overall, ET has a Moderate Buy consensus rating, based on 10 reviews evenly split between 5 Buys and 5 Holds. Shares are selling for $5.96, and the average price target of $9.70 suggests it has room for… Continue Reading…

Economy

“U.S. oil plunges 25% to trade below $13 a barrel to start another punishing week”

“June West Texas Intermediate crude CLM20, -26.62%, the U.S. benchmark, lost $4.20, or 25%, to trade at $12.69 a barrel, following a 32.3% decline for the week—its biggest such decline on record—for the commodity and a landmark plunge in the now-defunct May contract,… Continue Reading…